161 related articles for article (PubMed ID: 24258305)
1. Predictors of intact and C-terminal fibroblast growth factor 23 in Gambian children.
Braithwaite V; Jones KS; Assar S; Schoenmakers I; Prentice A
Endocr Connect; 2014; 3(1):1-10. PubMed ID: 24258305
[TBL] [Abstract][Full Text] [Related]
2. Iron status and fibroblast growth factor-23 in Gambian children.
Braithwaite V; Jarjou LM; Goldberg GR; Prentice A
Bone; 2012 Jun; 50(6):1351-6. PubMed ID: 22465847
[TBL] [Abstract][Full Text] [Related]
3. Intact fibroblast growth factor 23 and fragments in plasma from Gambian children.
Braithwaite V; Bruggraber SF; Prentice A
Osteoporos Int; 2013 Mar; 24(3):1121-4. PubMed ID: 22648001
[TBL] [Abstract][Full Text] [Related]
4. FGF23 is elevated in Gambian children with rickets.
Prentice A; Ceesay M; Nigdikar S; Allen SJ; Pettifor JM
Bone; 2008 Apr; 42(4):788-97. PubMed ID: 18234575
[TBL] [Abstract][Full Text] [Related]
5. Follow-up study of Gambian children with rickets-like bone deformities and elevated plasma FGF23: possible aetiological factors.
Braithwaite V; Jarjou LM; Goldberg GR; Jones H; Pettifor JM; Prentice A
Bone; 2012 Jan; 50(1):218-25. PubMed ID: 22023931
[TBL] [Abstract][Full Text] [Related]
6. Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans.
Imel EA; Peacock M; Gray AK; Padgett LR; Hui SL; Econs MJ
J Clin Endocrinol Metab; 2011 Nov; 96(11):3541-9. PubMed ID: 21880793
[TBL] [Abstract][Full Text] [Related]
7. Aetiology of nutritional rickets in rural Bangladeshi children.
Ahmed S; Goldberg GR; Raqib R; Roy SK; Haque S; Braithwaite VS; Pettifor JM; Prentice A
Bone; 2020 Jul; 136():115357. PubMed ID: 32276153
[TBL] [Abstract][Full Text] [Related]
8. The effects of maternal iron deficiency on infant fibroblast growth factor-23 and mineral metabolism.
Braithwaite VS; Prentice A; Darboe MK; Prentice AM; Moore SE
Bone; 2016 Feb; 83():1-8. PubMed ID: 26453792
[TBL] [Abstract][Full Text] [Related]
9. The aetiology of rickets-like lower limb deformities in Malawian children.
Braithwaite VS; Freeman R; Greenwood CL; Summers DM; Nigdikar S; Lavy CBD; Offiah AC; Bishop NJ; Cashman J; Prentice A
Osteoporos Int; 2016 Jul; 27(7):2367-2372. PubMed ID: 27059923
[TBL] [Abstract][Full Text] [Related]
10. Sex and Iron Modify Fibroblast Growth Factor 23 Concentration in 1-Year-Old Children.
Holmlund-Suila E; Enlund-Cerullo M; Valkama S; Hauta-Alus H; Rosendahl J; Helve O; Hytinantti T; Viljakainen H; Andersson S; Mäkitie O
J Clin Endocrinol Metab; 2017 Dec; 102(12):4526-4533. PubMed ID: 29029193
[TBL] [Abstract][Full Text] [Related]
11. Antenatal iron supplementation, FGF23, and bone metabolism in Kenyan women and their offspring: secondary analysis of a randomized controlled trial.
Braithwaite VS; Mwangi MN; Jones KS; Demir AY; Prentice A; Prentice AM; Andang'o PEA; Verhoef H
Am J Clin Nutr; 2021 May; 113(5):1104-1114. PubMed ID: 33675347
[TBL] [Abstract][Full Text] [Related]
12. FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets.
Imel EA; Hui SL; Econs MJ
J Bone Miner Res; 2007 Apr; 22(4):520-6. PubMed ID: 17227222
[TBL] [Abstract][Full Text] [Related]
13. FGF23 is correlated with iron status but not with inflammation and decreases after iron supplementation: a supplementation study.
Braithwaite V; Prentice AM; Doherty C; Prentice A
Int J Pediatr Endocrinol; 2012 Oct; 2012(1):27. PubMed ID: 23098062
[TBL] [Abstract][Full Text] [Related]
14. Low serum iron is associated with high serum intact FGF23 in elderly men: The Swedish MrOS study.
Lewerin C; Ljunggren Ö; Nilsson-Ehle H; Karlsson MK; Herlitz H; Lorentzon M; Ohlsson C; Mellström D
Bone; 2017 May; 98():1-8. PubMed ID: 28212898
[TBL] [Abstract][Full Text] [Related]
15. Iron and fibroblast growth factor 23 in X-linked hypophosphatemia.
Imel EA; Gray AK; Padgett LR; Econs MJ
Bone; 2014 Mar; 60():87-92. PubMed ID: 24325979
[TBL] [Abstract][Full Text] [Related]
16. Serum fibroblast growth factor 23, serum iron and bone mineral density in premenopausal women.
Imel EA; Liu Z; McQueen AK; Acton D; Acton A; Padgett LR; Peacock M; Econs MJ
Bone; 2016 May; 86():98-105. PubMed ID: 26965530
[TBL] [Abstract][Full Text] [Related]
17. Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease.
Wolf M; White KE
Curr Opin Nephrol Hypertens; 2014 Jul; 23(4):411-9. PubMed ID: 24867675
[TBL] [Abstract][Full Text] [Related]
18. Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice.
Farrow EG; Yu X; Summers LJ; Davis SI; Fleet JC; Allen MR; Robling AG; Stayrook KR; Jideonwo V; Magers MJ; Garringer HJ; Vidal R; Chan RJ; Goodwin CB; Hui SL; Peacock M; White KE
Proc Natl Acad Sci U S A; 2011 Nov; 108(46):E1146-55. PubMed ID: 22006328
[TBL] [Abstract][Full Text] [Related]
19. Impaired Growth Plate Maturation in XLH Is due to Both Excess FGF23 and Decreased 1,25-Dihydroxyvitamin D Signaling.
Yadav PS; Kobelski MM; Martins JS; Tao T; Liu ES; Demay MB
Endocrinology; 2023 Nov; 165(1):. PubMed ID: 38066669
[TBL] [Abstract][Full Text] [Related]
20. Oral Iron Replacement Normalizes Fibroblast Growth Factor 23 in Iron-Deficient Patients With Autosomal Dominant Hypophosphatemic Rickets.
Imel EA; Liu Z; Coffman M; Acton D; Mehta R; Econs MJ
J Bone Miner Res; 2020 Feb; 35(2):231-238. PubMed ID: 31652009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
